Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 18.59 is in line with its 5-year average of 17.22, near the high end of its 5-year range (15.53–19.61).
8.24% above its 12-month average of 17.17.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-27): 4.68.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-15T19:06:00.433Z. Historical observations retain their original dates. Historical series through 2026-09-11.
EARNINGS PER SHARE (EPS)
18.59
EARNINGS PER SHARE (EPS) AVG TTM
17.17
EARNINGS PER SHARE (EPS) AVG 3Y
16.90
EARNINGS PER SHARE (EPS) AVG 5Y
17.22
EARNINGS PER SHARE (EPS) AVG 10Y
12.33
EARNINGS PER SHARE (EPS) AVG 15Y
9.57
EARNINGS PER SHARE (EPS) AVG 20Y
7.70
CURRENT VS TTM AVG
+8.24%
CURRENT VS 3Y AVG
+9.98%
CURRENT VS 5Y AVG
+7.96%
CURRENT VS 10Y AVG
+50.81%
CURRENT VS 15Y AVG
+94.18%
CURRENT VS 20Y AVG
+141.53%
Thermo Fisher Scientific Inc.
Market Cap
$237.20B
Earnings Per Share (EPS)
18.59
TTM Avg
17.17
3Y Avg
16.90
5Y Avg
17.22
Market Cap
$252.85B
Earnings Per Share (EPS)
6.66
TTM Avg
5.57
3Y Avg
4.27
5Y Avg
3.27
Market Cap
$203.64B
Earnings Per Share (EPS)
16.09
TTM Avg
10.97
3Y Avg
11.67
5Y Avg
11.57
Market Cap
$188.95B
Earnings Per Share (EPS)
4.06
TTM Avg
3.38
3Y Avg
2.82
5Y Avg
2.39
Market Cap
$181.08B
Earnings Per Share (EPS)
-2.67
TTM Avg
3.61
3Y Avg
3.85
5Y Avg
3.41
Market Cap
$177.06B
Earnings Per Share (EPS)
3.11
TTM Avg
5.71
3Y Avg
4.66
5Y Avg
4.19
Market Cap
$146.73B
Earnings Per Share (EPS)
5.63
TTM Avg
5.20
3Y Avg
6.66
5Y Avg
6.73
Market Cap
$133.10B
Earnings Per Share (EPS)
8.79
TTM Avg
7.27
3Y Avg
5.84
5Y Avg
5.20
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $237.20B | 18.59 | 17.17 | 16.90 | 17.22 |
| AstraZeneca PLC (AZN)vs › | $252.85B | 6.66 | 5.57 | 4.27 | 3.27 |
| Amgen Inc. (AMGN)vs › | $203.64B | 16.09 | 10.97 | 11.67 | 11.57 |
| Novo Nordisk A/S (NVO)vs › | $188.95B | 4.06 | 3.38 | 2.82 | 2.39 |
| Gilead Sciences, Inc. (GILD)vs › | $181.08B | -2.67 | 3.61 | 3.85 | 3.41 |
| Abbott Laboratories (ABT)vs › | $177.06B | 3.11 | 5.71 | 4.66 | 4.19 |
| Pfizer Inc. (PFE)vs › | $156.88B | 0.76 | 1.39 | 2.19 | 2.39 |
| Danaher Corporation (DHR)vs › | $146.73B | 5.63 | 5.20 | 6.66 | 6.73 |
| Intuitive Surgical, Inc. (ISRG)vs › | $133.10B | 8.79 | 7.27 | 5.84 | 5.20 |
| UnitedHealth Group Incorporated (UNH)vs › | $342.15B | 15.55 | 14.44 | 18.63 | 18.19 |
Trailing EPS (TTM)
$18.59
Forward EPS (Est.)
$25.11
P/E Ratio
34.3
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 17.77 |
| 2024-12-31 | 16.58 |
| 2023-12-31 | 15.53 |
| 2022-12-31 | 17.73 |
| 2021-12-31 | 19.61 |
| 2020-12-31 | 16.10 |
| 2019-12-31 | 9.24 |
| 2018-12-31 | 7.31 |
| 2017-12-31 | 5.64 |
| 2016-12-31 | 5.12 |
| 2015-12-31 | 4.96 |
| 2014-12-31 | 4.76 |
| 2013-12-31 | 3.53 |
| 2012-12-31 | 3.24 |
| 2011-12-31 | 3.49 |
| 2010-12-31 | 2.57 |
| 2009-12-31 | 2.06 |
| 2008-12-31 | 2.34 |
| 2007-12-31 | 1.81 |
| 2006-12-31 | 0.86 |
| 2005-12-31 | 1.38 |
| 2004-12-31 | 2.22 |
| 2003-12-31 | 1.23 |
| 2002-12-31 | 1.84 |
| 2001-12-31 | 0.00 |
| 2000-12-31 | -0.22 |
| 1999-12-31 | -1.11 |
| 1998-12-31 | 1.12 |
| 1997-12-31 | 1.57 |
| 1996-12-31 | 1.35 |
